313 related articles for article (PubMed ID: 14715861)
1. Retinoic acid and retinoid X receptors are differentially expressed in thyroid cancer and thyroid carcinoma cell lines and predict response to treatment with retinoids.
Haugen BR; Larson LL; Pugazhenthi U; Hays WR; Klopper JP; Kramer CA; Sharma V
J Clin Endocrinol Metab; 2004 Jan; 89(1):272-80. PubMed ID: 14715861
[TBL] [Abstract][Full Text] [Related]
2. Breast cancer progression in MCF10A series of cell lines is associated with alterations in retinoic acid and retinoid X receptors and with differential response to retinoids.
Peng X; Yun D; Christov K
Int J Oncol; 2004 Oct; 25(4):961-71. PubMed ID: 15375546
[TBL] [Abstract][Full Text] [Related]
3. Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Sun SY; Yue P; Mao L; Dawson MI; Shroot B; Lamph WW; Heyman RA; Chandraratna RA; Shudo K; Hong WK; Lotan R
Clin Cancer Res; 2000 Apr; 6(4):1563-73. PubMed ID: 10778990
[TBL] [Abstract][Full Text] [Related]
4. [Expression of retinoic acid receptors in head and neck squamous cell carcinomas and their possible implication for chemoprevention].
Issing WJ
Laryngorhinootologie; 2001 Sep; 80(9):530-4. PubMed ID: 11555786
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of human ectocervical epithelial cell line proliferation and differentiation by retinoid X receptor- and retinoic acid receptor-specific retinoids.
Agarwal C; Chandraratna RA; Teng M; Nagpal S; Rorke EA; Eckert RL
Cell Growth Differ; 1996 Apr; 7(4):521-30. PubMed ID: 9052993
[TBL] [Abstract][Full Text] [Related]
6. All-trans-retinoic acid treatment inhibits the growth of retinoic acid receptor beta messenger ribonucleic acid expressing thyroid cancer cell lines but does not reinduce the expression of thyroid-specific genes.
Elisei R; Vivaldi A; Agate L; Ciampi R; Molinaro E; Piampiani P; Romei C; Faviana P; Basolo F; Miccoli P; Capodanno A; Collecchi P; Pacini F; Pinchera A
J Clin Endocrinol Metab; 2005 Apr; 90(4):2403-11. PubMed ID: 15623821
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Sun SY; Yue P; Dawson MI; Shroot B; Michel S; Lamph WW; Heyman RA; Teng M; Chandraratna RA; Shudo K; Hong WK; Lotan R
Cancer Res; 1997 Nov; 57(21):4931-9. PubMed ID: 9354460
[TBL] [Abstract][Full Text] [Related]
8. Early in vitro passages of breast cancer cells are differentially susceptible to retinoids and differentially express RARβ isoforms.
Peng X; Green A; Shilkaitis A; Zhu Y; Bratescu L; Christov K
Int J Oncol; 2011 Sep; 39(3):577-83. PubMed ID: 21667021
[TBL] [Abstract][Full Text] [Related]
9. Agonists of the retinoic acid- and retinoid X-receptors inhibit hepatocyte growth factor secretion and expression in U87 human astrocytoma cells.
Chattopadhyay N; Butters RR; Brown EM
Brain Res Mol Brain Res; 2001 Feb; 87(1):100-8. PubMed ID: 11223164
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel class of retinoic acid receptor beta-selective retinoid antagonists and their inhibitory effects on AP-1 activity and retinoic acid-induced apoptosis in human breast cancer cells.
Li Y; Hashimoto Y; Agadir A; Kagechika H; Zhang Xk
J Biol Chem; 1999 May; 274(22):15360-6. PubMed ID: 10336422
[TBL] [Abstract][Full Text] [Related]
11. RAR-, not RXR, ligands inhibit cell activation and prevent apoptosis in B-lymphocytes.
Lømo J; Smeland EB; Ulven S; Natarajan V; Blomhoff R; Gandhi U; Dawson MI; Blomhoff HK
J Cell Physiol; 1998 Apr; 175(1):68-77. PubMed ID: 9491782
[TBL] [Abstract][Full Text] [Related]
12. A novel RARbeta isoform directed by a distinct promoter P3 and mediated by retinoic acid in breast cancer cells.
Peng X; Maruo T; Cao Y; Punj V; Mehta R; Das Gupta TK; Christov K
Cancer Res; 2004 Dec; 64(24):8911-8. PubMed ID: 15604252
[TBL] [Abstract][Full Text] [Related]
13. Retinoid X receptor-gamma and peroxisome proliferator-activated receptor-gamma expression predicts thyroid carcinoma cell response to retinoid and thiazolidinedione treatment.
Klopper JP; Hays WR; Sharma V; Baumbusch MA; Hershman JM; Haugen BR
Mol Cancer Ther; 2004 Aug; 3(8):1011-20. PubMed ID: 15299084
[TBL] [Abstract][Full Text] [Related]
14. Differential effects of chromosome 3p deletion on the expression of the putative tumor suppressor RAR beta and on retinoid resistance in human squamous carcinoma cells.
Zou CP; Youssef EM; Zou CC; Carey TE; Lotan R
Oncogene; 2001 Oct; 20(47):6820-7. PubMed ID: 11687961
[TBL] [Abstract][Full Text] [Related]
15. Bexarotene via CBP/p300 induces suppression of NF-κB-dependent cell growth and invasion in thyroid cancer.
Cras A; Politis B; Balitrand N; Darsin-Bettinger D; Boelle PY; Cassinat B; Toubert ME; Chomienne C
Clin Cancer Res; 2012 Jan; 18(2):442-53. PubMed ID: 22142826
[TBL] [Abstract][Full Text] [Related]
16. Regulation of retinoid-induced differentiation in embryonal carcinoma PCC4.aza1R cells: effects of retinoid-receptor selective ligands.
Mills KJ; Vollberg TM; Nervi C; Grippo JF; Dawson MI; Jetten AM
Cell Growth Differ; 1996 Mar; 7(3):327-37. PubMed ID: 8838863
[TBL] [Abstract][Full Text] [Related]
17. Retinoid receptors in gastric cancer: expression and influence on prognosis.
Hu KW; Chen FH; Ge JF; Cao LY; Li H
Asian Pac J Cancer Prev; 2012; 13(5):1809-17. PubMed ID: 22901127
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive expression analysis of retinoic acid receptors and retinoid X receptors in non-small cell lung cancer: implications for tumor development and prognosis.
Brabender J; Metzger R; Salonga D; Danenberg KD; Danenberg PV; Hölscher AH; Schneider PM
Carcinogenesis; 2005 Mar; 26(3):525-30. PubMed ID: 15618235
[TBL] [Abstract][Full Text] [Related]
19. Retinoid X receptor-specific retinoids inhibit the ability of retinoic acid receptor-specific retinoids to increase the level of insulin-like growth factor binding protein-3 in human ectocervical epithelial cells.
Hembree JR; Agarwal C; Beard RL; Chandraratna RA; Eckert R
Cancer Res; 1996 Apr; 56(8):1794-9. PubMed ID: 8620495
[TBL] [Abstract][Full Text] [Related]
20. Heteroarotinoids inhibit head and neck cancer cell lines in vitro and in vivo through both RAR and RXR retinoic acid receptors.
Zacheis D; Dhar A; Lu S; Madler MM; Klucik J; Brown CW; Liu S; Clement F; Subramanian S; Weerasekare GM; Berlin KD; Gold MA; Houck JR; Fountain KR; Benbrook DM
J Med Chem; 1999 Oct; 42(21):4434-45. PubMed ID: 10543887
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]